The E in ESG: Medtechs Are Getting To Grips With The ‘True Purpose’ Of Carbon Zero
Late starters health care and medtech are now making progress in the race to zero
BD and Boston Scientific exemplify the approach of “big medtech” as it knuckles down to meet global climate change responsibilities. But the industry will have to work together with health systems to achieve the larger race to zero goals – especially those of scope 3.
You may also be interested in...
The E in ESG: Beware Green Claims That Might Backfire
Health care companies making carbon neutrality claims must tread a careful line while ensuring full accountability. CMS Vienna partner Gabriela Staber points to some of the risks businesses should be aware of when making sustainability claims.
Outlook 2023: The Irresistible Forces Shaping Medtech Markets And Industry
The integration of smart connected care, broadening of diagnosis and therapy into new settings and improvement of chronic disease outcomes will continue to shape the market for devices and diagnostics companies for years to come. But there is also a maze of short-term macroeconomic issues for medtechs to work through.
Putting The E In ESG: The Provider’s View Of Sustainability Compliance
As the health care sector moves from linear to circular, medtechs, providers and patients all have roles to play in ensuring that current strategies, practices and behaviors contribute to guarantee a sustainable future. Part one of a short series on this theme looks as best practice for providers.